WEST PHARMACEUTICAL SERVICES INC (WST)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NYSE
$352.79
+1.79%
Investingg Score
59.7 / 100
Hold
Business overview
- Gross margin of 35.9%
- Operating margin of 19%
- Free cash flow margin of 15.3%
These margins indicate solid profitability but limited upside.
Financial health
- Balance Sheet score of 99
- Market capitalization of $25.4 billion
- Free cash flow yield of 1.9%
The company has a strong balance sheet and size, though cash generation relative to price is low.
- Gross Margin
- 35.9%
- Operating Margin
- 19.0%
- Current Ratio
- 3.0x
- Debt / Equity
- 0.06
- Free Cash Flow (TTM)
- $0.5B
- Interest Coverage
- 39x
Valuation
- P/E ratio of 44.99
- EV/EBITDA of 29.08
- Price‑to‑sales ratio of 7.72
Valuation multiples are high, suggesting the stock may be expensive.
- P/E (TTM)
- 45.0x
- Forward P/E
- 36.0x
- Price / Sales
- 7.7x
- EV / EBITDA
- 29.1x
- FCF Yield
- 1.8%
Key risks
- No specific risks identified in the provided data.
- Data unavailable for detailed risk factors.
Market cap $25.4B · data as of 2026-08-20
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze WST with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.